ADMS

Adamas Pharmaceuticals, Inc.
ADMS

Overview Fund Activity
Delisted

ADMS was delisted on the 23rd of November, 2021.

Back to rankings

77 hedge funds and large institutions have $276M invested in Adamas Pharmaceuticals, Inc. in 2017 Q2 according to their latest regulatory filings, with 10 funds opening new positions, 21 increasing their positions, 29 reducing their positions, and 3 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
77
Holders Change
+7
Holders Change %
+10%
% of All Funds
1.92%
Holding in Top 10
3
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.07%
New
10
Increased
21
Reduced
29
Closed
3
Calls
$453K
Puts
$478K
Net Calls
-$25K
Net Calls Change
+$383K

Top Buyers

1
AC
Armistice Capital
New York
$20.3M
2
BWCA
Brenner West Capital Advisors
New York
$24.8M
3
RPAM
Rhenman & Partners Asset Management
Sweden
$6.44M
4
AI
Axiom Investors
Connecticut
$1.77M
5
Point72 Asset Management
Point72 Asset Management
Connecticut
$2.01M

Top Sellers

1
GPP
Great Point Partners
Connecticut
$38.8M
2
OTPPB
Ontario Teachers' Pension Plan Board
Ontario, Canada
$4.33M
3
PVI
Pura Vida Investments
New York
$1.38M
4
JPMorgan Chase & Co
JPMorgan Chase & Co
New York
$18K
5
BlackRock
BlackRock
New York
$20.8M
Name Holding Trade Value Shares
Change 		Shares
Change %
MAM
76
Meeder Asset Management
Ohio
$2K -$3.24K -149 -62%
Citigroup
77
Citigroup
New York
$2K +$1.98K +97 +9,700%
TI
78
Trexquant Investment
Connecticut
– -$287K -16,372 Closed
GWM
79
Geneos Wealth Management
Colorado
– -$5K -290 Closed
LTFS
80
Ladenburg Thalmann Financial Services
Florida
– -$2K -100 Closed
1 2 3
4